Document is current
Any future updates will be listed below
-
Authors
Sarivalasis, Apostolos
Boudousquié, Caroline
Balint, Klara
Stevenson, Brian J.
Gannon, Philippe O.
Iancu, Emanuela Marina
Rossier, Laetitia
Martin Lluesma, Silvia
Mathevet, Patrice
Sempoux, Christine
Coukos, George
Dafni, Urania
Harari, Alexandre
Bassani-Sternberg, Michal
Kandalaft, Lana E. https://orcid.org/0000-0002-1575-6674
-
Funding
Funding for this research was provided by:
Ovacure
Centre Hospitalier Universitaire Vaudois
- License Information
-
More Information
Article History
Received: 12 September 2019
Accepted: 9 November 2019
First Online: 26 November 2019
Ethics approval and consent to participate
: Before start of the trial (CHUV-DO-0005-OVACURE-2017), the trial protocol, informed consent document and any other trial documents were submitted to the authorities. The study was approved by the regulatory authority Swiss Agency of Therapeutic Products (Swissmedic Ref.: 2019TpP1004) and it is currently under final evaluation by the independent Ethics Committee of Canton Vaud (CER-VD Ref.: 2019-01141).
: The procedures set out in this trial protocol, pertaining to the conduct, evaluation and documentation of this trial, are designed to ensure that all persons involved in the trial abide by Good Clinical Practice and the ethical principles described in the current revision of the Declaration of Helsinki. The trial will be carried out in keeping with local legal and regulatory requirements.
: Not applicable.
: The authors declare that the research is conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
